Viewing Study NCT03817320


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT03817320
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-17
First Post: 2019-01-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Organization: